Abstract:【Objective】 To investigate the efficacy of Kuntai capsule as adjuvant therapy to hormone replacement therapy for premature ovarian failure. 【Methods】 A total of 100 patients with premature ovarian failure treated in the 83rd Group Army Hospital of the Chinese People's Liberation Army from January 2024 to December 2025 were enrolled and divided into control group (hormone replacement therapy) and observation group (Kuntai capsule combined with hormone replacement therapy) according to different treatment regimens, with 50 cases in each group. Hormone levels including estradiol (E2), follicle-stimulating hormone (FSH) and luteinizing hormone (LH), modified Kupperman index score, endometrial thickness, ovarian ultrasound indicators [mean ovarian diameter (MOD), antral follicle count (AFC), peak systolic velocity (PSV) of ovarian artery, resistance index (RI) and pulsatility index (PI)], and incidence of adverse reactions were compared between the two groups. 【Results】 After treatment, the level of E2 in the observation group was higher than that in the control group (P<0.05), while the levels of FSH and LH were lower than those in the control group (all P<0.05). After treatment, the modified Kupperman index score of the observation group was lower and endometrial thickness was thicker compared with the control group (all P<0.05). MOD, AFC and ovarian artery PSV in the observation group were higher (all P<0.05), whereas ovarian artery RI and PI were lower (all P<0.05). There was no statistically significant difference in the total incidence of adverse reactions between the two groups (P>0.05). 【Conclusion】 Adjuvant treatment with Kuntai capsule combined with hormone replacement therapy can promote the recovery of hormone levels and improve ovarian function in patients with premature ovarian failure, with favorable safety profile.
范莉莉. 坤泰胶囊辅助激素替代疗法治疗卵巢早衰的效果[J]. 医学临床研究, 2026, 43(8): 1265-1267.
FAN Lili. Efficacy of Kuntai Capsule Adjuvant to Hormone Replacement Therapy in the Treatment of Premature Ovarian Failure. JOURNAL OF CLINICAL RESEARCH, 2026, 43(8): 1265-1267.